phone Contact Us

Company Updates

Opharmic Announces New Platform Technology Website for MeticTouch®

Opharmic Announces New Site

Hong Kong, 5 January 2024

Opharmic Launches Dedicated MeticTouch® Platform Website for Ocular Drug Delivery

Opharmic Technology (HK) Limited is excited to announce the launch of a dedicated website for its innovative MeticTouch® platform technology for non-invasive ocular drug delivery.

The new microsite serves as a comprehensive resource for stakeholders, providing detailed information about MeticTouch®'s unique ultrasound-mediated approach to enhancing drug permeability in ocular tissues. Visitors can explore the science behind the technology, potential clinical applications, and its advantages over traditional invasive delivery methods.

MeticTouch® utilizes precisely controlled ultrasound energy to temporarily and safely increase the permeability of ocular barriers, enabling effective delivery of therapeutic agents to target tissues in the eye. This non-invasive platform has the potential to transform treatment for various ophthalmic conditions, improving patient comfort, compliance, and outcomes while reducing the need for injections or other invasive procedures.

Opharmic designed the new website to clearly communicate the technology's mechanism, preclinical data, and development roadmap. The site also highlights the company's broader mission to advance patient-centric innovations in ophthalmology and beyond, complementing the MeticStim® platform for cell stimulation.

The new programme website aligns with Opharmic's commitment to transparency and stakeholder engagement. It features technical overviews, publication references, news updates, and contact options for collaboration inquiries.

Author

Opharmic Technology